For Medical Professionals

Industry News

A new discovery in the fight against cancer: tumor cells switch to a different mode
4/29/2016

When medication is used to shut off the oxygen supply to tumor cells, the cells adapt their metabolism in the medium term - by switching over to producing energy without oxygen.

Recent cancer diagnosis associated with increased risk of mental health disorders
4/28/2016

A recent cancer diagnosis was associated with increased risk for some mental health disorders and increased use of psychiatric medications, according to a new study published online by JAMA...

Diagnostics for everyone: A faster and more effective detector of fungal infections
4/28/2016

Fungal infections are a serious problem in modern health care. A critical factor in their successful treatment is time: the faster they are detected, the more effectively dangerous infections can be...

Multiple myeloma: Phase 3 trial results for the oral proteasome inhibitor ixazomib published in the New England Journal of Medicine
4/28/2016

Results from the TOURMALINE-MM1 Phase 3 clinical study, published in the New England Journal of Medicine, have shown that oral ixazomib capsules in combination with lenalidomide and dexamethasone...

Coal-tar based sealcoats on driveways, parking lots far more toxic than suspected
4/28/2016

The pavement sealcoat products used widely around the nation on thousands of asphalt driveways and parking lots are significantly more toxic and mutagenic than previously suspected, according to a...

Study: 93 percent of advanced leukemia patients in remission after immunotherapy
4/28/2016

'Extraordinary' but short-term results from early-stage trial of engineered immune cells.

Lynparzatm (olaparib) now available to NHS patients in England and Wales with BRCA-mutated ovarian cancer
4/27/2016

AstraZeneca has announced that LynparzaTM (olaparib) is now available for NHS patients in England and Wales with platinum-sensitive relapsed (PSR) BRCA-mutated (BRCAm) high-grade serous ovarian...

Excessive tests don't benefit patient, do increase cost in age-related immune disorder
4/27/2016

A series of tests physicians routinely order to help diagnose and follow their patients with an elevated antibody level that is a marker for cancer risk, often do not benefit the patient but do...

Cholesterol levels, not statins, influence colorectal cancer risk
4/27/2016

Indication bias' may explain link between statin use and cancer risk. Long-term use of the cholesterol-lowering drugs known as statins does not appear to decrease a patient's risk of...

New research shows quality of life measures not widely used in cancer care
4/27/2016

A new study, conducted by the not-for-profit research organisation RAND Europe, has found that measures and tools used to assess quality of life are not being used widely in the treatment and care...